• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不可切除肝细胞癌的经导管化疗栓塞:当前认知与未来方向

Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions.

作者信息

Maleux Geert, van Malenstein Hannah, Vandecaveye Vincent, Heye Sam, Vaninbroukx Johan, Nevens Frederik, Verslype Chris

机构信息

Department of Radiology, University Hospitals Leuven, Leuven, Belgium.

出版信息

Dig Dis. 2009;27(2):157-63. doi: 10.1159/000218348. Epub 2009 Jun 22.

DOI:10.1159/000218348
PMID:19546554
Abstract

Transarterial chemoembolization (TACE) is considered the gold standard for the treatment of unresectable hepatocellular carcinoma (HCC) in patients with a preserved liver function and in the absence of clear extrahepatic tumor spread. This review article deals with the radiological and clinical workup, the interventional technique of chemoembolization for HCC and gives an overview of the common as well as some rare and dramatic complications of TACE. Finally, some new trends and advances in clinical research with regard to the interventional management of HCC are discussed.

摘要

经动脉化疗栓塞术(TACE)被认为是治疗肝功能良好且无明确肝外肿瘤扩散的不可切除肝细胞癌(HCC)患者的金标准。这篇综述文章探讨了放射学和临床检查、HCC化疗栓塞的介入技术,并概述了TACE的常见以及一些罕见和严重的并发症。最后,讨论了HCC介入治疗方面临床研究的一些新趋势和进展。

相似文献

1
Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions.不可切除肝细胞癌的经导管化疗栓塞:当前认知与未来方向
Dig Dis. 2009;27(2):157-63. doi: 10.1159/000218348. Epub 2009 Jun 22.
2
Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.肝细胞癌的射频消融与化疗栓塞
Cancer J. 2008 Mar-Apr;14(2):117-22. doi: 10.1097/PPO.0b013e31816a0fac.
3
Interventional treatments for hepatocellular carcinoma.肝细胞癌的介入治疗
Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):495-500.
4
Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.经动脉化疗栓塞术、经动脉化疗和经动脉化疗治疗肝细胞癌。
Semin Oncol. 2010 Apr;37(2):89-93. doi: 10.1053/j.seminoncol.2010.03.007.
5
[Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].经动脉化疗栓塞联合高强度聚焦超声消融治疗大肝癌的临床疗效
Zhonghua Yi Xue Za Zhi. 2009 Mar 24;89(11):754-7.
6
[Radiological treatment of hepatocellular carcinoma in 2010].2010年肝细胞癌的放射治疗
Cancer Radiother. 2011 Feb;15(1):21-7. doi: 10.1016/j.canrad.2010.11.002. Epub 2011 Jan 22.
7
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.中晚期肝细胞癌治疗策略的演进:经动脉化疗栓塞治疗的现有证据和专家意见
Cancer Treat Rev. 2011 May;37(3):212-20. doi: 10.1016/j.ctrv.2010.07.006. Epub 2010 Aug 17.
8
Ruptured hepatocellular carcinoma following chemoembolization: a western experience.化疗栓塞后肝细胞癌破裂:西方经验
Hepatobiliary Pancreat Dis Int. 2007 Feb;6(1):49-51.
9
Chemoembolization of hepatocellular carcinoma--what to tell the skeptics: review and meta-analysis.肝细胞癌的化疗栓塞术——如何回应质疑者:综述与荟萃分析
Tech Vasc Interv Radiol. 2002 Sep;5(3):122-6. doi: 10.1053/tvir.2002.36418.
10
Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?经动脉化疗栓塞术(TACE)治疗不可切除 HCC:新的生命开始了吗?
Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):356-62.

引用本文的文献

1
Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma.D-TACE+HAIC+乐伐替尼与 D-TACE+乐伐替尼治疗不可切除的大肝癌的疗效和安全性比较分析。
BMC Cancer. 2024 Nov 18;24(1):1422. doi: 10.1186/s12885-024-13179-5.
2
Predictors and risk factors of bile duct injury after transcatheter arterial chemoembolization for hepatocellular carcinoma.经导管动脉化疗栓塞治疗肝细胞癌后胆管损伤的预测因素和危险因素。
BMC Cancer. 2024 Sep 2;24(1):1085. doi: 10.1186/s12885-024-12864-9.
3
Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study.
TACE+Donafenib+Toripalimab 与 TACE+Sorafenib 治疗不可切除肝细胞癌的疗效和安全性分析:一项回顾性研究。
BMC Cancer. 2023 Oct 25;23(1):1033. doi: 10.1186/s12885-023-11535-5.
4
Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma.经动脉化疗栓塞术可延长不可切除肝细胞癌患者的长期生存期。
Medicine (Baltimore). 2018 Aug;97(33):e11872. doi: 10.1097/MD.0000000000011872.
5
Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation.等待肝移植名单上的肝细胞癌患者的桥接和降期治疗
Transl Gastroenterol Hepatol. 2016 Apr 14;1:34. doi: 10.21037/tgh.2016.03.04. eCollection 2016.
6
Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.肿瘤血管生成及碘油沉积作为预测不可切除肝细胞癌患者经动脉化疗栓塞术后疾病进展风险的早期影像学标志物。
Oncotarget. 2016 Feb 9;7(6):7241-52. doi: 10.18632/oncotarget.6892.
7
Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma.经导管动脉化疗栓塞术治疗不可切除肝细胞癌患者。
Hepat Mon. 2014 Dec 28;14(12):e25792. doi: 10.5812/hepatmon.25792. eCollection 2014 Dec.
8
Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.肝细胞癌(HCC)诊断与管理中的影像学及影像引导介入——证据综述
Iran J Radiol. 2012 Nov;9(4):167-77. doi: 10.5812/iranjradiol.8242. Epub 2012 Nov 20.
9
Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization.经动脉栓塞治疗后肝癌患者外在凋亡途径活性增加。
World J Gastroenterol. 2011 Nov 14;17(42):4675-81. doi: 10.3748/wjg.v17.i42.4675.